Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Wu J, Singh K, Lin A, Meadows AM, Wu K, Shing V, Bley M, Hassanzadeh S, Huffstutler RD, Schmidt MS, Blanco LP, Tian R, Brenner C, Pirooznia M, Kaplan MJ, Sack MN.
Wu J, et al. Among authors: bley m.
J Clin Invest. 2022 Mar 1;132(5):e139828. doi: 10.1172/JCI139828.
J Clin Invest. 2022.
PMID: 35025762
Free PMC article.